In China, breast cancer was the sond cause of incidence rates among all the cancers, with both increasing incidence and mortality [2].
Aromatase inhibitors (AIs) are used in the treatment of metastatic breast cancer [3 , 4] and in the adjuvant setting [5 - 7].